Status:
UNKNOWN
High-flow Nasal Oxygen Therapy to Prevent Extubation Failure in Adult Trauma Intensive Care Patients
Lead Sponsor:
Hamad Medical Corporation
Conditions:
Intensive Care
Airway Extubation
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
A significant proportion of patients who are intubated for trauma-related injuries, will fail the extubation process. This means that, when the decision has been made to remove the endotracheal tube, ...
Detailed Description
High-flow nasal oxygen therapy (HFNO) has emerged over the last decade as a viable adjunct in the management of patients suffering from, or at risk of, hypoxemic respiratory failure. The mechanisms of...
Eligibility Criteria
Inclusion
- Adult intubated and ventilated patients who are victims of trauma and are being cared for on the Trauma Intensive Care Unit will be considered eligible for the study when they are considered fit for extubation.
Exclusion
- Patients who cannot be extubated (including patients requiring tracheostomy)
- Patients with cribriform plate fractures
- Patients with nasal occlusion for any reason
- Patients with unstable mid-face fractures
Key Trial Info
Start Date :
October 17 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
February 1 2024
Estimated Enrollment :
450 Patients enrolled
Trial Details
Trial ID
NCT06110390
Start Date
October 17 2020
End Date
February 1 2024
Last Update
October 31 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hamad General Hospital
Doha, Qatar